Detalles de la búsqueda
1.
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
N Engl J Med
; 380(12): 1103-1115, 2019 03 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30779531
2.
A phase I study of danusertib (PHA-739358) in adult patients with accelerated or blastic phase chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant or intolerant to imatinib and/or other second generation c-ABL therapy.
Haematologica
; 100(7): 898-904, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25887498
3.
Impact of Prior Cytoreductive Nephrectomy on Efficacy in Patients with Synchronous Metastatic Renal Cell Carcinoma Treated with Avelumab plus Axitinib or Sunitinib: Post Hoc Analysis from the JAVELIN Renal 101 Phase 3 Trial.
Eur Urol
; 85(1): 8-12, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37852850
4.
Randomized phase II study of danusertib in patients with metastatic castration-resistant prostate cancer after docetaxel failure.
BJU Int
; 111(1): 44-52, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22928785
5.
Prospective Cardiovascular Surveillance of Immune Checkpoint Inhibitor-Based Combination Therapy in Patients With Advanced Renal Cell Cancer: Data From the Phase III JAVELIN Renal 101 Trial.
J Clin Oncol
; 40(17): 1929-1938, 2022 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35239416
6.
Influence of pharmacogenetic variability on the pharmacokinetics and toxicity of the aurora kinase inhibitor danusertib.
Invest New Drugs
; 29(5): 953-62, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20182906
7.
Quantification of the proliferation index of human dermal fibroblast cultures with the ArrayScan high-content screening reader.
Drug Discov Today
; Suppl: 31-42, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-23570164
8.
Quantification of the proliferation index of human dermal fibroblast cultures with the ArrayScan high-content screening reader.
J Biomol Screen
; 9(3): 232-43, 2004 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15146854
9.
A phase I dose-escalation study of danusertib (PHA-739358) administered as a 24-hour infusion with and without granulocyte colony-stimulating factor in a 14-day cycle in patients with advanced solid tumors.
Clin Cancer Res
; 15(21): 6694-701, 2009 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19825950
10.
Phase I pharmacokinetic and pharmacodynamic study of the aurora kinase inhibitor danusertib in patients with advanced or metastatic solid tumors.
J Clin Oncol
; 27(30): 5094-101, 2009 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-19770380
Resultados
1 -
10
de 10
1
Próxima >
>>